EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Signaling Pathways Associated with Inflammatory Bowel Disease

Jia Wei, Jiexiong Feng

Recent Patents on Inflammation & Allergy Drug Discovery · 01.06.2010 · 4 (2) · 105-117

DOI: 10.2174/187221310791163071 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Recent Patents on Inflammation & Allergy Drug Discovery, erschienen am 01.06.2010. Verfasst von Jia Wei und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P R China. Hauptthemen laut MEDLINE: Signal Transduction. Die Arbeit wurde bisher 155-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD) consists of Crohn's disease (CD) and ulcerative colitis (UC). It is thought to be caused by genetic, abnormal immune response of the intestinal immune system and dysfunction of intestinal mucosal barrier against enteric bacteria. Mutational genes can affect the development of IBDs via certain signaling pathways. The abnormal signaling pathways play an important role in the inflammatory process and can lead to dysregulation of the inflammatory response and are crucial in the pathogenesis of IBDs. The signaling pathways mainly include P38 MAPK, JNK MAPK, PI3K/Akt, NF-kappaB signaling pathways. Intestinal microorganisms play a key role in the initiation and maintenance of disease. Disorders of signaling pathways including TLR, NF-kappaB can act on the intestinal barrier, and cause uninhibitedly release of effector T cells which are the central cells mediating inflammation in CD. This review highlights relevant patents and a new insight of signaling pathways associated with IBDs will help to develop better therapeutic approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Signal TransductionAnimalsColitis, UlcerativeCrohn DiseaseHumansInflammationIntestinesNF-kappa BPatents as TopicT-LymphocytesToll-Like Receptors

Substanzen

NF-kappa BToll-Like Receptors

Autor:innen und Institutionen

  • Department of Pediatric Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P R China.

Zitieren

APA

Wei, J., & Feng, J. (2010). Signaling Pathways Associated with Inflammatory Bowel Disease. Recent Patents on Inflammation & Allergy Drug Discovery, 4(2), 105-117. https://doi.org/10.2174/187221310791163071

Vancouver

Wei J, Feng J. Signaling Pathways Associated with Inflammatory Bowel Disease. Recent Patents on Inflammation & Allergy Drug Discovery. 2010;4(2):105-117. doi:10.2174/187221310791163071

BibTeX
@article{Wei2010,
  author = {Wei, Jia and Feng, Jiexiong},
  title = {Signaling Pathways Associated with Inflammatory Bowel Disease},
  journal = {Recent Patents on Inflammation & Allergy Drug Discovery},
  year = {2010},
  volume = {4},
  number = {2},
  pages = {105--117},
  doi = {10.2174/187221310791163071}
}
Kostenlos starten →